Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma

Pseudoprogression: Relevance With Respect to Treatment of High-Grade Gliomas

(2011) James Fink et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation – incidence, therapeutic strategies, and outcome

(2011) Lutz Dörner et al.   JOURNAL OF CLINICAL NEUROSCIENCE

The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series

(2010) Alessandro Della Puppa et al.   ACTA NEUROCHIRURGICA

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

(2008) R. Stupp et al.   ANNALS OF ONCOLOGY

Survival from brain tumours in England and Wales up to 2001

(2008) B Rachet et al.   BRITISH JOURNAL OF CANCER

Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience

(2008) Michael Sabel et al.   CURRENT MEDICAL RESEARCH AND OPINION

Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies

(2008) Steven H Lin et al.   Expert Review of Anticancer Therapy

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

(2008) Matthew J. McGirt et al.   JOURNAL OF NEUROSURGERY